NasdaqCM - Delayed Quote • USD
PDS Biotechnology Corporation (PDSB)
At close: April 24 at 4:00 PM EDT
After hours: April 24 at 7:17 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 5 |
| Avg. Estimate | -0.37 | -0.36 | -1.48 | -1.61 |
| Low Estimate | -0.45 | -0.45 | -1.75 | -1.97 |
| High Estimate | -0.28 | -0.28 | -1.11 | -1.3 |
| Year Ago EPS | -0.32 | -0.37 | -1.39 | -1.48 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 3 |
| Avg. Estimate | -- | -- | -- | 370k |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 1.1M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.31 | -0.35 | -0.45 | -0.44 |
| EPS Actual | -0.32 | -0.37 | -0.35 | -0.35 |
| Difference | -0.01 | -0.02 | 0.1 | 0.09 |
| Surprise % | -3.20% | -5.70% | 22.20% | 20.50% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.37 | -0.36 | -1.48 | -1.61 |
| 7 Days Ago | -0.37 | -0.36 | -1.48 | -1.61 |
| 30 Days Ago | -0.44 | -0.42 | -1.7 | -1.63 |
| 60 Days Ago | -0.44 | -0.42 | -1.7 | -1.63 |
| 90 Days Ago | -0.44 | -0.42 | -1.71 | -1.63 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 3 | 3 | 5 | 3 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | PDSB | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -15.60% | -- | -- | 1.50% |
| Next Qtr. | 2.70% | -- | -- | 11.40% |
| Current Year | -6.50% | -- | -- | 5.20% |
| Next Year | -8.80% | -- | -- | 13.40% |
| Next 5 Years (per annum) | 86.40% | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | B. Riley Securities: Buy to Buy | 3/28/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/27/2024 |
| Maintains | Oppenheimer: Outperform to Outperform | 11/15/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 10/11/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 9/27/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 9/20/2023 |
Related Tickers
MREO Mereo BioPharma Group plc
2.7800
0.00%
XFOR X4 Pharmaceuticals, Inc.
1.2900
+4.88%
DAWN Day One Biopharmaceuticals, Inc.
15.19
-8.71%
EFTR eFFECTOR Therapeutics, Inc.
1.8500
-4.64%
LPTX Leap Therapeutics, Inc.
3.2900
+2.81%
CLRB Cellectar Biosciences, Inc.
3.0600
-1.61%
OCUL Ocular Therapeutix, Inc.
4.6450
-7.10%
ABEO Abeona Therapeutics Inc.
3.1700
-7.04%
MCRB Seres Therapeutics, Inc.
0.7295
-4.01%
TGTX TG Therapeutics, Inc.
13.98
-1.89%